The term enterprise imaging (EI) entered our industry’s vernacular about a decade ago. It was introduced both as a concept and as an approach to managing patient images across the care continuum.



The pandemic forced many elective procedures, including most areas of cancer screening, to be put on hold to prioritize more critical healthcare needs and help slow the spread of the coronavirus. This included breast screening. 


November 12, 2020 – Konica Minolta Healthcare Americas Inc. and DiA Imaging Analysis Ltd. jointly announce the expanded deployment of the LVivo Cardiac ultrasound artificial intelligence (AI) Toolbox on the Exa Cardio PACS platform.


As the COVID-19 pandemic spread around the world, hospitals learned all that they were capable of. With a staggering number of patients testing their capabilities, healthcare workers heroically rose to the occasion. At the same time, this unprecedented situation exposed some of the inefficiencies inherent in even the best healthcare systems.



Medical imaging procedures such as single-photon emission computed tomography (SPECT) scans, myocardial perfusion scans and bone scans are used to diagnose issues such as heart disease and cancer, and deliver lifesaving treatment to tens of thousands of patients every day around the world.


There is a high incidence of ultrasound work-related musculoskeletal disorders (WRMSD) among sonographers. Aside from the lasting personal toll, sonographer injury intensifies workforce shortages, which can cause unexpected operational and financial challenges for your ultrasound department.

November 12, 2020 — GE Healthcare announced U.S. FDA 510(k) clearance of its SIGNA 7.0T magnetic resonance imaging (MRI) scanner.


The use of cardiovascular computed tomography angiography (CCTA) is one of the areas that has seen a sudden increase in use and value since the start of the ongoing COVID-19 pandemic. While SARS-CoV-2 has significantly impacted cardiovascular care delivery, with a large reduction in elective diagnostic testing and face-to-face patient care, it also resulted in a necessary re-examination of how cardiac care is delivered.



Just as it has been difficult for us to predict the course of this pandemic, so too have healthcare organizations been challenged to predict and evolve their operations to optimize patient care — as well as revenue. In the initial wave, healthcare’s technology needs shifted rapidly. Some organizations immediately shifted as clusters emerged, increasing bed capacity, converting non-clinical spaces to intensive care units and expanding telehealth programs.


What a year this has been. As I write this column in late-October, The New York Times (NYT) reported over 8.7 million cases of novel coronavirus in the U.S. to date, and more than 225,600 deaths. At least 534 new coronavirus deaths and 74,323 new cases were reported in the United States on Oct. 26 alone. Over the past week, there have been an average of 71,092 cases per day, an increase of 40 percent from the average two weeks earlier. Globally, the numbers are just as grim.

Subscribe Now